Inflammation and stroke: Therapeutic effects of adenoviral expression of secretory leukocyte protease inhibitor

被引：6
作者：
Feuerstein, G [1 ]
机构：
[1] Wyeth Res, Translat Med, Collegeville, PA 19426 USA
来源：
FRONTIERS IN BIOSCIENCE-LANDMARK | 2006年 / 11卷
关键词：
nervous system; neuron; brain; stroke; inflammation; protease inhibitors; and leukocytes; SLPI; review;
D O I：
10.2741/1920
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Inflammation is a fundamental reaction of the organism aimed to protect, defend and amend diverse forms of injuries. Stroke, an ischemic condition of the brain, provokes acute and chronic inflammatory reactions composed of brain cells as well as circulating immune inflammatory cells. In response to ischemia, brain cells transcribe and express inflammatory proteins that orchestrate numerous biochemical pathways, some of which of potential detrimental effects. This review paper is aimed to delineate strategies that may enable the discovery of novel therapeutic targets for the discovery of drugs for stroke. Soluble Leukocyte Protease Inhibitor ( SLPI) serves as a prime example for this strategy.
引用
收藏
页码：1750 / 1757
页数：8
相关论文
共 59 条
  • [1] EXPRESSION OF THE SECRETORY LEUKOPROTEASE INHIBITOR GENE IN EPITHELIAL-CELLS
    ABE, T
    KOBAYASHI, N
    YOSHIMURA, K
    TRAPNELL, BC
    KIM, H
    HUBBARD, RC
    BREWER, MT
    THOMPSON, RC
    CRYSTAL, RG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) : 2207 - 2215
  • [2] Cytokines and acute neurodegeneration
    Allan, SM
    Rothwell, NJ
    [J]. NATURE REVIEWS NEUROSCIENCE, 2001, 2 (10) : 734 - 744
  • [3] Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing
    Ashcroft, GS
    Lei, KJ
    Jin, WW
    Longenecker, G
    Kulkarni, AB
    Greenwell-Wild, T
    Hale-Donze, H
    McGrady, G
    Song, XY
    Wahl, SM
    [J]. NATURE MEDICINE, 2000, 6 (10) : 1147 - 1153
  • [4] Ischemic preconditioning and brain tolerance - Temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression
    Barone, FC
    White, RF
    Spera, PA
    Ellison, J
    Currie, RW
    Wang, XK
    Feuerstein, GZ
    [J]. STROKE, 1998, 29 (09) : 1937 - 1950
  • [5] Tumor necrosis factor-alpha - A mediator of focal ischemic brain injury
    Barone, FC
    Arvin, B
    White, RF
    Miller, A
    Webb, CL
    Willette, RN
    Lysko, PG
    Feuerstein, GZ
    [J]. STROKE, 1997, 28 (06) : 1233 - 1244
  • [6] REPERFUSION INCREASES NEUTROPHILS AND LEUKOTRIENE-B4 RECEPTOR-BINDING IN RAT FOCAL ISCHEMIA
    BARONE, FC
    SCHMIDT, DB
    HILLEGASS, LM
    PRICE, WJ
    WHITE, RF
    FEUERSTEIN, GZ
    CLARK, RK
    LEE, EV
    GRISWOLD, DE
    SARAU, HM
    [J]. STROKE, 1992, 23 (09) : 1337 - 1347
  • [7] Inflammatory mediators and stroke: New opportunities for novel therapeutics
    Barone, FC
    Feuerstein, GZ
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (08) : 819 - 834
  • [8] THE SERINE-PROTEASE INHIBITOR OF CARTILAGE MATRIX IS NOT A CHONDROCYTIC GENE-PRODUCT
    BOHM, B
    AIGNER, T
    KINNE, R
    BURKHARDT, H
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 207 (02): : 773 - 779
  • [9] CEHNG YD, 2004, NEURX, V1, P36
  • [10] Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage
    Chapman, GA
    Moores, K
    Harrison, D
    Campbell, CA
    Stewart, BR
    Strijbos, PJLM
    [J]. JOURNAL OF NEUROSCIENCE, 2000, 20 (15)
123456